Usnea Uva Ursi Supreme
Withdrawn from the US market on 22 December 2022 (according to the DSLD)
Gaia Herbs, food supplement from the US market
Label withdrawn from the US market. Usnea Uva Ursi Supreme (Gaia Herbs), a food supplement au code-barres 751063343503, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Gaia Herbs
- Barcode
- 751063343503
- Form
- Liquid
- One serving
- 2 ml
- Servings
- up to 4 servings per day
- Other ingredients (in English, as written)
- Alcohol, Water
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Proprietary Extract Blend | Blend | 2 mL |
| Echinacea purpurea root extract (Echinacea purpurea) | Plant | not stated |
| Uva Ursi (Arctostaphylos uva-ursi) leaf extract (Arctostaphylos uva-ursi) | Plant | not stated |
| Echinacea angustifolia root extract | Plant | not stated |
| Usnea Lichen (Usnea barbata) | Plant | not stated |
| Echinacea purpurea seed extract (Echinacea purpurea) | Plant | not stated |
| Echinacea purpurea aerial parts extract (Echinacea purpurea) | Plant | not stated |
| Coptis (Coptis chinensis) root extract | Plant | not stated |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Usnea Uva Ursi Supreme
Entered into DSLD on 22 December 2017. Withdrawn from the US market on 29 August 2019 (according to the DSLD).- Active ingredient added : Coptis (quantity not stated)
- Active ingredient added : Echinacea angustifolia (quantity not stated)
- Active ingredient added : Echinacea purpurea (quantity not stated)
- Active ingredient added : Echinacea purpurea (quantity not stated)
- Active ingredient added : Echinacea purpurea (quantity not stated)
- Active ingredient added : Usnea (quantity not stated)
- Active ingredient added : Uva Ursi (quantity not stated)
- Active ingredient removed : Coptis (Coptis chinensis) root extract (quantity not stated)
- Active ingredient removed : Echinacea angustifolia root extract (quantity not stated)
- Active ingredient removed : Echinacea purpurea aerial parts extract (quantity not stated)
- Active ingredient removed : Echinacea purpurea root extract (quantity not stated)
- Active ingredient removed : Echinacea purpurea seed extract (quantity not stated)
- Active ingredient removed : Usnea Lichen (quantity not stated)
- Active ingredient removed : Uva Ursi (Arctostaphylos uva-ursi) leaf extract (quantity not stated)
- Same quantity, different name: Proprietary Extract Blend (Combination) in this version; Proprietary Extract Blend on the displayed label (2 mL)
Official label: Usnea Uva Ursi Supreme
Entered into DSLD on 21 December 2012. Withdrawn from the US market on 5 August 2017 (according to the DSLD).- Active ingredient added : PROPRIETARY BLEND (quantity not stated)
- Active ingredient removed : Coptis (Coptis chinensis) root extract (quantity not stated)
- Active ingredient removed : Echinacea angustifolia root extract (quantity not stated)
- Active ingredient removed : Echinacea purpurea aerial parts extract (quantity not stated)
- Active ingredient removed : Echinacea purpurea root extract (quantity not stated)
- Active ingredient removed : Echinacea purpurea seed extract (quantity not stated)
- Active ingredient removed : Proprietary Extract Blend (2 mL)
- Active ingredient removed : Usnea Lichen (quantity not stated)
- Active ingredient removed : Uva Ursi (Arctostaphylos uva-ursi) leaf extract (quantity not stated)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Echinacea purpurea root extract
Read the warning, when it applies and the studies cited
ECHINACEA - ECHINACEA PURPUREA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a progressive systemic disease such as tuberculosis, collagenosis, multiple sclerosis, or an immune system disorder (EMA 2015; Gardner and McGuffin 2013; Brinker 2010).
Sources cited by Health Canada (3)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2015: European Medicines Agency (GB). EMA/HMPC/48704/2014. European Union herbal monograph on Echinacea purpurea (L.) Moench, herba recens. Final. [Accessed 2024 December 11]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-echinacea-purpurea-l-moench-herba-recens_en.pdf
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications to suppress the immune system (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Known adverse reactions
Condition of application: Preparations containing herb top.
Stop use if hypersensitivity/allergy occurs (MHRA 2018; EMA 2015; Kligler 2003; WHO 1999).
Sources cited by Health Canada (5)
- EMA 2015: European Medicines Agency (GB). EMA/HMPC/48704/2014. European Union herbal monograph on Echinacea purpurea (L.) Moench, herba recens. Final. [Accessed 2024 December 11]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-echinacea-purpurea-l-moench-herba-recens_en.pdf
- Kligler B. 2003. Echinacea. American Family Physician 67(1):77-80. [Accessed 2024 February 22]. Available from: http://www.aafp.org/afp/2003/0101/p77.html
- MHRA 2018: Medicines and Healthcare products Regulatory Agency (GB). Press release: Echinacea herbal products should not be used in children under 12 years old. [Accessed 2024 December 11]. Available from: https://webarchive.nationalarchives.gov.uk/ukgwa/20140208035927/http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON180627
- WHO 1999: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 1. Geneva (CH): World Health Organization; 1999.
- OMS 1999: Organisation mondiale de la santé (OMS). Monographs on Selected Medicinal Plants : Volume 1. Geneva (CHE) : Organisation mondiale de la santé; 1999.
- Uva Ursi (Arctostaphylos uva-ursi) leaf extract
Read the warning, when it applies and the studies cited
Bearberry - Arctostaphylos Uva-Ursi
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Applies to products providing 60 milligrams or more of dried leaves and/or products providing 20 milligrams or more of Arbutin, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver disorder, fever, painful urination (dysuria), spasms, or blood in urine (EMA 2018; Duke 2002; Newall 1996).
Sources cited by Health Canada (2)
- EMA 2018: EMA/HMPC/750269/2016. European Union herbal monograph on Arctostaphylos uva-ursi (L.) Spreng., folium. London (GB): European Medicines Agency: Committee on Herbal Medicinal Products (HMPC); 2018 January 30. [Accessed 2024 June 11]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-arctostaphylos-uva-ursi-l-spreng-folium-revision-2_en.pdf
- Newall CA, Anderson LA, Phillipson JD. Herbal Medicines: A guide for health-care professionals. London (GB): The Pharmaceutical Press; 1996.
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Do not use if you are pregnant or breastfeeding (EMA 2018; Brinker 2010; ESCOP 2003; WHO 2002; Blumenthal 2000; Mills and Bone 2000; Bradley 1992).
Sources cited by Health Canada (8)
- Blumenthal M, Goldberg A, Brinckmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
- Bradley PR, editor. British Herbal Compendium Volume 1: A Handbook of Scientific Information on Widely Used Plant Drugs - Companion Volume 1 of the British Herbal Pharmacopoeia. Bournemouth (GB): British Herbal Medicine Association; 1992.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2018: EMA/HMPC/750269/2016. European Union herbal monograph on Arctostaphylos uva-ursi (L.) Spreng., folium. London (GB): European Medicines Agency: Committee on Herbal Medicinal Products (HMPC); 2018 January 30. [Accessed 2024 June 11]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-arctostaphylos-uva-ursi-l-spreng-folium-revision-2_en.pdf
- ESCOP 2003: European Scientific Cooperative of Phytotherapy. ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition completely revised and expanded. Exeter (GB): European Scientific Cooperative on Phytotheraphy; 2003.
- Mills S, Bone K. Principles and Practice of Phytotherapy, Modern Herbal Medicine. Edinburg (GB): Churchill LYes Soivingston; 2000.
- WHO 2002: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 3. Geneva (CH): World Health Organization; 2002.
- OMS 2002: Organisation mondiale de la santé (OMS). Monographs on Selected Medicinal Plants : Volume 3. Genève (CH): Organisation mondiale de la santé; 2002.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Gaia Herbs
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Usnea Uva Ursi Supreme : étiquette retirée du marché américain (Gaia Herbs): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/751063343503-usnea-uva-ursi-supreme-gaia-herbs, updated 22 December 2022.